The Foresight Institute welcomes Lawrence Lessig of Stanford University, Amory Lovins of Rocky Mountain Institute, and Christopher Hook of the Mayo Clinic to its Board of Advisors, adding experts in the environmental, bioethics, and legal areas.
Press Release from the Foresight Institute:
Palo Alto, CA – November 20, 2003 – Foresight Institute, a nonprofit educational organization formed to prepare society for the impact of molecular nanotechnology, has appointed Lawrence Lessig, intellectual property law expert at Stanford University; Amory B. Lovins, environmental technology leader from Rocky Mountain Institute; and C. Christopher Hook, MD, a Mayo clinic bioethicist to their Board of Advisors.
"Foresight Institute was founded to guide society in managing the ethical, environmental and legal issues raised by molecular nanotechnology and its future capabilities," said Christine Peterson, President, Foresight Institute. "Having these leaders in their respective fields advising us should make a big difference in our efforts to maximize and spread the benefits of molecular nanotechnology, and to minimize potential drawbacks."
Amory B. Lovins, Chief Executive Officer of Rocky Mountain Institute, is a consultant and experimental physicist educated at Harvard and Oxford. He has received an Oxford MA (by virtue of being a don), eight honorary doctorates, a MacArthur Fellowship, the Heinz, Lindbergh, Right Livelihood ("Alternative Nobel"), World Technology, and Time Hero for the Planet awards. His work focuses on transforming the automobile, real estate, electricity, water, semiconductor, and several other manufacturing sectors toward advanced resource productivity.
Lawrence Lessig is a Professor of Law at Stanford University and founder of the school?s Center for Internet and Society. Prior to joining the Stanford faculty, he was the Berkman Professor of Law at Harvard University. Lessig was also a fellow at Wissenschaftskollege zu Brelin, and a Professor at the University of Chicago Law. He is author of The Future of Ideas: Fate of the Commons in the Connected World and Code and Other Laws of Cyberspace. More recently, Lessig represented web site operator Eric Eldred before the U.S. Supreme Court in the groundbreaking case Eldred v. Ashcroft, a challenge to the 1998 Sonny Bono Copyright Extension Act.
C. Christopher Hook, M.D., is Chair of the Mayo Clinical Ethics Council and Director of Ethics Education, Mayo Graduate School of Medicine in Rochester. Following medical school at the University of Illinois College of Medicine at Peoria, he completed training programs in Internal Medicine, Hematology, and Medical Oncology at the Mayo Graduate School of Medicine, and is Board Certified in all three areas by the American Board of Internal Medicine. He then joined the staff in the Department of Hematology/Oncology at the Mayo Clinic Jacksonville. He has been instrumental in founding several bioethics forums and created the Mayo Medical Center Ethics Consultation Service, the Reproductive Medicine Advisory Board, the DNA Research Committee, and the Mayo Clinical Ethics Council, the last three of which he still chairs. He is presently putting together the Transplantation Ethics Advisory Board for Mayo.
Foresight Institute ? Current Board of Advisors
The new advisors will join a stellar group including Stewart Brand, Global Business Network; Jamie Dinkelacker, Ph.D., Advisor to NanoBusiness Alliance; Doug Engelbart, Ph.D., Bootstrap Institute; John Gilmore, Electronic Frontier Foundation; Prof. Arthur Kantrowitz, Dartmouth College; Ray Kurzweil, Kurzweil Technologies; Prof. Marvin Minksy, MIT; and Peter Schwartz, Global Business Network.
About Foresight Institute
Foresight Institute is the leading public interest organization involved in nanotechnology and emerging technologies. Formed in 1986 by K. Eric Drexler and Christine Peterson, Foresight dedicates itself to providing education, information, and networking support on the topic of molecular nanotechnology and molecular manufacturing. The organization?s goal is to guide emerging technologies to improve the human condition and enhance critical discussion, thus improving public and private policy decisions.